Eli Lilly Analyst Ratings
Barclays Remains a Buy on Eli Lilly & Co (LLY)
Options -- The Striking Price: There's a Smarter Way to 'Buy the Dip' Next Time -- Barron's
Airbnb Is a Great Company That Had a Rough Week. Its Stock Is a Buy. -- Barrons.com
Eli Lilly Price Target Raised to $1000.00/Share From $875.00 by Wells Fargo
Eli Lilly & Co: A Balanced Hold Rating Amid Growth and Competitive Challenges
Redburn Atlantic Adjusts Eli Lilly Price Target to $640 From $600
Jefferies Remains a Buy on Eli Lilly & Co (LLY)
CrowdStrike in Focus as Stifel Cuts Price Target Ahead of Earnings
ARC Independent Adjusts Price Target on Amazon.com to $205 From $220
Eli Lilly Analyst Ratings
Eli Lilly & Co (LLY) Buy Rating Affirmed on Strong HFpEF Data and Competitive Edge Over Novo Nordisk (NVO)
UBS Reaffirms Their Hold Rating on Alphabet Class A (GOOGL)
Intel in Focus as Mizuho Downgrades on Continued Headwinds; Gelsinger Buys Shares
CICC Initiates Apple at Outperform With $250.20 Price Target
Redburn Atlantic Adjusts Price Target on Microsoft to $500 From $530, Maintains Buy Rating
Daiwa Securities Adjusts Price Target on Amazon.com to $219 From $220, Maintains Buy Rating
Nvidia Stock Creeps Up. Why Investors Are Hesitating to Buy the Dip.
The AI Crunch Spells Opportunity for This Stock, Says Analyst -- Barrons.com
Daiwa Securities Adjusts Price Target on Meta Platforms to $600 From $515, Maintains Buy Rating